|
US3898330A
(en)
|
1973-08-01 |
1975-08-05 |
Squibb & Sons Inc |
Corticosteroid phosphate salts/neomycin sulfate ophthalmic
|
|
US4525359A
(en)
|
1982-12-10 |
1985-06-25 |
Greenway Frank L Iii |
Treatment for selective weight control
|
|
NZ212204A
(en)
|
1984-06-04 |
1988-07-28 |
Merck & Co Inc |
Growth-promoting compositions containing hydroxylic compounds
|
|
GB8426672D0
(en)
|
1984-10-22 |
1984-11-28 |
Erba Farmitalia |
Pharmaceutical compositions
|
|
JPH0696521B2
(ja)
|
1986-01-31 |
1994-11-30 |
千寿製薬株式会社 |
眼局所投与用眼圧降下剤
|
|
FR2602423B1
(fr)
|
1986-08-08 |
1989-05-05 |
Ethypharm Sa |
Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
|
|
US5270305A
(en)
|
1989-09-08 |
1993-12-14 |
Glaxo Group Limited |
Medicaments
|
|
CA2030174C
(en)
|
1990-01-10 |
1996-12-24 |
Anthony H. Cincotta |
Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
|
|
US5126147A
(en)
|
1990-02-08 |
1992-06-30 |
Biosearch, Inc. |
Sustained release dosage form
|
|
US5919827A
(en)
|
1990-07-11 |
1999-07-06 |
Sepracor Inc. |
Method for treating asthma using optically pure R(-) salmeterol
|
|
SE9302777D0
(sv)
|
1993-08-27 |
1993-08-27 |
Astra Ab |
Process for conditioning substances
|
|
SG48301A1
(en)
|
1991-12-18 |
1998-04-17 |
Astra Ab |
New combination
|
|
US5314916A
(en)
|
1993-04-19 |
1994-05-24 |
Alcon Laboratories, Inc. |
B2 adrenegic agonists and use thereof in the treatment of glaucoma
|
|
US6316443B1
(en)
|
1994-08-04 |
2001-11-13 |
Merck & Co., Inc. |
Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a β-adrenergic antagonist
|
|
GB9512854D0
(en)
|
1995-06-23 |
1995-08-23 |
Wellcome Found |
Novel formulation
|
|
US5855913A
(en)
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
|
WO1998010758A1
(en)
|
1996-09-13 |
1998-03-19 |
The Regents Of The University Of California |
Methods for treatment of retinal diseases
|
|
ES2317657T3
(es)
|
1996-09-19 |
2009-04-16 |
The Regents Of The University Of Michigan |
Polimeros que contienen polisacaridos tales como alginatos o alginatos modificados.
|
|
SE9700135D0
(sv)
|
1997-01-20 |
1997-01-20 |
Astra Ab |
New formulation
|
|
TW469832U
(en)
|
1997-03-14 |
2001-12-21 |
Astra Ab |
Inhalation device
|
|
HUP0104439A3
(en)
|
1997-03-18 |
2002-08-28 |
Basf Ag |
Pharmaceutical compositions for modulating responsiveness to corticosteroids and use thereof
|
|
US6656508B2
(en)
|
1997-04-17 |
2003-12-02 |
Amgen Inc. |
Sustained-release alginate gels
|
|
BR9815470A
(pt)
|
1997-04-30 |
2001-10-23 |
Bridge Pharma Inc |
Composição e processo usando um eutÈmero
|
|
US20010044584A1
(en)
|
1997-08-28 |
2001-11-22 |
Kensey Kenneth R. |
In vivo delivery methods and compositions
|
|
SE9703407D0
(sv)
|
1997-09-19 |
1997-09-19 |
Astra Ab |
New use
|
|
JPH11106334A
(ja)
*
|
1997-09-30 |
1999-04-20 |
Saitama Daiichi Seiyaku Kk |
尿失禁治療剤
|
|
US20030095925A1
(en)
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
|
|
US20040152664A1
(en)
|
1998-09-02 |
2004-08-05 |
Allergan, Inc. |
Prednisolone compositions
|
|
US6384259B1
(en)
|
1998-11-16 |
2002-05-07 |
Medimmune Oncology, Inc. |
Stable amorphous amifostine compositions and dosage form
|
|
WO2001019373A2
(en)
|
1999-09-17 |
2001-03-22 |
Basf Aktiengesellschaft |
Methods and compositions for modulating responsiveness to corticosteroids
|
|
GB9924992D0
(en)
|
1999-10-21 |
1999-12-22 |
Glaxo Group Ltd |
Pharmaceutical aerosol formulations
|
|
US6569903B2
(en)
|
1999-12-07 |
2003-05-27 |
Rohto Pharmaceutical Co., Ltd. |
Ophthalmic compositions
|
|
US20040208910A1
(en)
|
2000-04-26 |
2004-10-21 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of adrenergic agents
|
|
GB0012260D0
(en)
|
2000-05-19 |
2000-07-12 |
Astrazeneca Ab |
Novel composition
|
|
AUPQ797700A0
(en)
|
2000-06-06 |
2000-06-29 |
Austin Research Institute, The |
Vaccine
|
|
FI20002215A0
(fi)
|
2000-10-06 |
2000-10-06 |
Orion Yhtymae Oyj |
Yhdistelmäpartikkelit
|
|
US6936426B2
(en)
|
2000-10-06 |
2005-08-30 |
Harbor-Ucla Research And Education Institute |
Detection of antibody mediated inflammatory auto-immune disorders
|
|
FI20002216A0
(fi)
|
2000-10-06 |
2000-10-06 |
Orion Yhtymae Oyj |
Yhdistelmäpartikkelit astman hoitoon
|
|
AU2002210395A1
(en)
|
2000-11-03 |
2002-05-15 |
Histotech Aps |
A device and a method for sectioning of tissue blocks
|
|
EP1347743B1
(en)
|
2000-12-07 |
2006-03-08 |
Universiteit Utrecht Holding B.V. |
Composition for treatment of inflammatory disorders
|
|
AU2002251831A1
(en)
|
2001-01-30 |
2002-08-12 |
The Regents Of The University Of Michigan |
Methods for sustained release local delivery of drugs for ablation of unwanted tissue
|
|
UA77656C2
(en)
|
2001-04-07 |
2007-01-15 |
Glaxo Group Ltd |
S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
|
|
US20030055026A1
(en)
|
2001-04-17 |
2003-03-20 |
Dey L.P. |
Formoterol/steroid bronchodilating compositions and methods of use thereof
|
|
NZ528888A
(en)
|
2001-04-30 |
2005-10-28 |
Glaxo Group Ltd |
Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
|
|
GB0124523D0
(en)
|
2001-10-12 |
2001-12-05 |
Glaxo Group Ltd |
Pharmaceutical combination
|
|
RU2279292C2
(ru)
|
2001-10-24 |
2006-07-10 |
Пари Гмбх |
Набор для приготовления фармацевтической композиции
|
|
US6625078B2
(en)
|
2002-02-11 |
2003-09-23 |
United Memories, Inc. |
Look-ahead refresh for an integrated circuit memory
|
|
AU2003246829A1
(en)
|
2002-02-19 |
2003-09-09 |
Resolution Chemicals Limited |
Solvent-based sterilisation of pharmaceuticals
|
|
US20050009798A1
(en)
|
2002-02-20 |
2005-01-13 |
Sepracor Inc. |
Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
|
|
US6643212B1
(en)
|
2002-04-18 |
2003-11-04 |
United Memories, Inc. |
Simultaneous function dynamic random access memory device technique
|
|
AU2003263717A1
(en)
|
2002-09-25 |
2004-04-19 |
Astrazeneca Ab |
A COMBINATION OF A LONG-ACTING Beta2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES
|
|
CN1694689A
(zh)
|
2002-09-30 |
2005-11-09 |
阿库斯菲尔公司 |
供吸入的缓释多孔微粒
|
|
US20040208833A1
(en)
|
2003-02-04 |
2004-10-21 |
Elan Pharma International Ltd. |
Novel fluticasone formulations
|
|
EP1613266A4
(en)
|
2003-04-15 |
2009-05-06 |
Theraquest Biosciences Llc |
METHOD FOR TREATING PAIN AND COMPOSITIONS FOR USE THEREOF
|
|
US9808471B2
(en)
|
2003-04-16 |
2017-11-07 |
Mylan Specialty Lp |
Nasal pharmaceutical formulations and methods of using the same
|
|
WO2004103057A2
(en)
*
|
2003-05-15 |
2004-12-02 |
The University Of Georgia Research Foundation, Inc. |
Compositions and methods for inducing adipose tissue cell death
|
|
AU2004241746A1
(en)
|
2003-05-22 |
2004-12-02 |
Nycomed Gmbh |
Salmeterol and ciclesonide combination
|
|
SE0302029D0
(sv)
|
2003-07-07 |
2003-07-07 |
Astrazeneca Ab |
Novel process
|
|
TWI359675B
(en)
|
2003-07-10 |
2012-03-11 |
Dey L P |
Bronchodilating β-agonist compositions
|
|
GB0316290D0
(en)
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Novel compounds
|
|
GB2403655A
(en)
|
2003-07-11 |
2005-01-12 |
Cipla Ltd |
Combined pharmaceutical product comprising a beta-2 adrenoreceptor agonist & an antihistamine for treatment of respiratory diseases such as asthma
|
|
CA2532874A1
(en)
|
2003-07-22 |
2005-02-03 |
Baxter International Inc. |
Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
|
|
CN1856296A
(zh)
|
2003-09-30 |
2006-11-01 |
阿库斯菲尔公司 |
可注射的、口服、或局部用缓释药物制剂
|
|
US20050075900A1
(en)
|
2003-10-02 |
2005-04-07 |
Arguimbau Vincent C. |
Method and apparatus for bulk food marking and tracking with supplier rating system
|
|
DE10347994A1
(de)
|
2003-10-15 |
2005-06-16 |
Pari GmbH Spezialisten für effektive Inhalation |
Wässrige Aerosol-Zubereitung
|
|
ES2383525T3
(es)
|
2003-11-05 |
2012-06-21 |
Sarcode Bioscience Inc. |
Moduladores de la adhesión celular
|
|
JP2007515402A
(ja)
*
|
2003-11-20 |
2007-06-14 |
アルターアゴン プロプライエタリー リミテッド |
哺乳動物および鳥類の体脂肪および体重の減少方法
|
|
KR100573828B1
(ko)
|
2003-12-29 |
2006-04-26 |
주식회사 하이닉스반도체 |
셀데이터의 손실을 방지하기 위한 반도체 메모리 소자
|
|
US20080270175A1
(en)
|
2003-12-31 |
2008-10-30 |
Klinger Advanced Aesthetics, Inc. |
Systems and methods using a dynamic expert system to provide patients with aesthetic improvement procedures
|
|
US20050212152A1
(en)
|
2004-03-23 |
2005-09-29 |
Reens Daniel J |
System and method for humidifying homes and commercial sites
|
|
US7754230B2
(en)
|
2004-05-19 |
2010-07-13 |
The Regents Of The University Of California |
Methods and related compositions for reduction of fat
|
|
US7317023B2
(en)
|
2004-07-21 |
2008-01-08 |
Theravance, Inc. |
Diaryl ether β2 adrenergic receptor agonists
|
|
WO2006057637A1
(en)
|
2004-11-24 |
2006-06-01 |
Seo Hong Yoo |
Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
|
|
KR20070104645A
(ko)
|
2005-02-18 |
2007-10-26 |
산텐 세이야꾸 가부시키가이샤 |
스테로이드 화합물의 부작용 경감 또는 회피 방법
|
|
US20100215710A1
(en)
|
2005-04-08 |
2010-08-26 |
The Regents Of The University Of California |
Beta-2 Adrenergic Receptor Agonists and Antagonists and Modulation of Wound Healing
|
|
US7931909B2
(en)
|
2005-05-10 |
2011-04-26 |
Allergan, Inc. |
Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
|
|
CN1706501A
(zh)
|
2005-05-27 |
2005-12-14 |
沈阳药科大学 |
亲脂性药物环糊精包合物的制备方法
|
|
ATE552032T1
(de)
|
2005-07-14 |
2012-04-15 |
Lithera Inc |
Verbesserte lipolytikum-formulierung mit hinhaltender wirkstofffreigabe für die arealbehandlung von fettgewebe
|
|
CN101252842A
(zh)
*
|
2005-07-14 |
2008-08-27 |
利波西拉公司 |
用于局部脂肪组织治疗的持续释放的增强性脂肪分解性制剂
|
|
US8158152B2
(en)
|
2005-11-18 |
2012-04-17 |
Scidose Llc |
Lyophilization process and products obtained thereby
|
|
FR2893845B1
(fr)
|
2005-11-30 |
2010-10-29 |
Galderma Sa |
Composition sous forme de spray comprenant un corticoide et une phase huileuse
|
|
EP1973523A2
(en)
|
2005-12-15 |
2008-10-01 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
|
US20070178051A1
(en)
|
2006-01-27 |
2007-08-02 |
Elan Pharma International, Ltd. |
Sterilized nanoparticulate glucocorticosteroid formulations
|
|
JP2009532489A
(ja)
|
2006-04-03 |
2009-09-10 |
テバ ファーマシューティカル インダストリーズ リミティド |
薬剤微粒子
|
|
DE102007026979A1
(de)
|
2006-10-06 |
2008-04-10 |
Friedrich Siller |
Inhalationsvorrichtung
|
|
CN101626759B
(zh)
*
|
2006-10-17 |
2014-08-06 |
利特拉公司 |
用于治疗甲状腺眼病的组合物和制剂
|
|
WO2008048770A1
(en)
|
2006-10-17 |
2008-04-24 |
Lipothera, Inc. |
Methods, compositions, and formulations for the treatment of thyroid eye disease
|
|
WO2008066775A2
(en)
|
2006-11-22 |
2008-06-05 |
Duncan Diane I |
Compositions and methods to reduce fat and retract skin
|
|
CN101678083A
(zh)
|
2007-04-04 |
2010-03-24 |
瑟瑞技术公司 |
Ghrh分子的药物制剂
|
|
EA018918B1
(ru)
*
|
2007-04-24 |
2013-11-29 |
Экейше Фарма Лимитед |
КОМБИНАЦИЯ, СОДЕРЖАЩАЯ β-АГОНИСТ И ПРОГЕСТИН, И ЕЁ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРЕДОТВРАЩЕНИЯ АТРОФИИ МЫШЕЧНОЙ ТКАНИ
|
|
US20090208492A1
(en)
|
2007-06-14 |
2009-08-20 |
Elan Pharmaceuticals, Inc. |
Lyophilized Immunoglobulin Formulations and Methods of Preparation
|
|
PT2170348T
(pt)
|
2007-06-22 |
2016-11-02 |
Dompé Farm S P A |
Comprimidos efervescentes para utilização por via inalatória
|
|
US20090143343A1
(en)
|
2007-11-13 |
2009-06-04 |
Meritage Pharma, Inc. |
Compositions for the treatment of inflammation of the gastrointestinal tract
|
|
AU2008331928B2
(en)
|
2007-12-03 |
2012-08-16 |
Bridge Pharma, Inc. |
Use of RR/SR-ractopamine
|
|
US9132084B2
(en)
*
|
2009-05-27 |
2015-09-15 |
Neothetics, Inc. |
Methods for administration and formulations for the treatment of regional adipose tissue
|
|
SG2014014351A
(en)
*
|
2010-01-15 |
2014-07-30 |
Lithera Inc |
Lyophilized cake formulations
|